Guru Ownership Trend
Guru Analysis for NewAmsterdam Pharma Company N.V. (NAMS)
NewAmsterdam Pharma Company N.V. (NAMS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $298.97 M.
Top institutional holders include Andreas Halvorsen and Lee Ainslie.
Institutional sentiment is currently Bullish. This is evidenced by a $49.64 M net inflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 118.5%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for NewAmsterdam Pharma Company N.V. (NAMS)
Major holders include Andreas Halvorsen ($142.46 M), Lee Ainslie ($110.75 M), Stanley Druckenmiller ($104.05 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 10.94 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $49.64 M, with 5 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in NAMS during the most recent reporting period.
Yes, 3 managers opened new positions in NAMS, and 2 increased their existing holdings. The total reported buy value was $49.64 M.
